At Aavis Pharmaceuticals we continuously do research to develop new formulations for existing products to potentially enhance their therapeutic efficiency as well as to new drug molecules to improve patient compliance.

Our highly experienced and dedicated management team ensures timely execution of projects, Cost effectiveness and quality of the projects and Confidentiality and protection of intellectual property at the same time.

Working with the customers to provide full product development services in flexible, adaptable and customized partnership models is all Aavis looks forward to.


Keeping people healthy is a public service in true sense and Aavis is well positioned to meet the demands of small and big pharmaceutical industry players by dedicating all its energies towards the better health of the people.

The competitive advantages include:
  • From Proof of concept to Clinical batch manufacturing
  • Comprehensive technology platforms tailored to optimize the performance of individual drug substances.
  • Unrivalled expertise in both proprietary and non-proprietary drug delivery technologies.
  • IP protection and exclusivity
  • Quality, service and confidentiality while meeting the strict time lines
  • Short time project execution

Our 40,000 sq. ft. state of the art full cGMP R&D facility includes 15 process rooms and 4 analytical laboratories.

Equipment available for

  • Granulation
  • Coating (special coating pans available for minitablet coating)
  • Fluid bed coating/granulation
  • Single, Bi and Tri layer tablet compression
  • Compression coat/tablet in a tablet compression
  • Nano milling
  • Spray Drying
  • Extrusion/Spheronization

Analytical services

  • Process development
  • Method development & validation
  • Chemical testing
  • Microbial testing